RecruitingNCT05844059

Lower Urinary Tract Symptoms After Intravesical Therapy

Lower Urinary Tract Symptoms After Intravesical Therapy With Mitomycin C or BCG in Patients With Carcinoma of the Bladder


Sponsor

Ludwig-Maximilians - University of Munich

Enrollment

60 participants

Start Date

Apr 21, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

With this prospective, observational study, we would like to investigate the effect of instillation therapy using BCG or mitomycin C on short- and long-term irritative and obstructive lower urinary tract symptoms using validated questionnaires. The study will objectify the lower urinary tract symptoms and thereby provide better recommendations for therapy with mitomycin C or BCG.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study tracks urinary symptoms such as urgency, frequency, pain, and incontinence in people with bladder cancer who are receiving intravesical therapy — medications instilled directly into the bladder. The goal is to better understand and document how this common treatment affects daily quality of life. **You may be eligible if...** - You have bladder cancer that requires intravesical instillation therapy - Your tumor has been completely removed prior to starting instillation therapy - You have not received intravesical chemotherapy in the past 3 months **You may NOT be eligible if...** - You are unable or unwilling to complete questionnaires - You have contraindications to instillation therapy such as drug allergies or a severely weakened immune system Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERValidated questionnaires

BPIC-SS, ICIQ-OABqol, IIEF-EF oder FSFI, ICIQ-MLUTS oder ICIQ-FLUTS


Locations(1)

Nikolaos Pyrgidis

Munich, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05844059


Related Trials